New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
July 31, 2015
16:22 EDTINTCStocks end week higher in U.S. despite selloff in China
Subscribe for More Information
07:27 EDTJNJJohnson & Johnson drug business likely to remain resilient, says Wells Fargo
Subscribe for More Information
July 29, 2015
16:10 EDTVRTXVertex raises 2015 KALYDECO sales outlook to $575M-$590M
Subscribe for More Information
16:09 EDTVRTXVertex reports Q2 EPS (54c), consensus (58c)
Reports Q2 revenue $166.1M, consensus $149.7M. Reports KALYDECO product revenue $154.9M vs. $113.1M last year.
15:59 EDTVRTXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Facebook (FB), consensus 47c... MetLife (MET), consensus $1.48... Williams (WMB), consensus 24c... Vertex (VRTX), consensus (58c)... O'Reilly Automotive (ORLY), consensus $2.26... NXP Semiconductors (NXPI), consensus $1.37... Marriott (MAR), consensus 81c... Fiserv (FISV), consensus 94c... Western Digital (WDC), consensus $1.45... SBA Communications (SBAC), consensus 9c... Whole Foods (WFM), consensus 45c... Lincoln National (LNC), consensus $1.53... Lam Research (LRCX), consensus $1.47... ServiceNow (NOW), consensus (2c)... Qorvo (QRVO), consensus $1.06... Hologic (HOLX), consensus 39c.
15:08 EDTVRTXNotable companies reporting after market close
Subscribe for More Information
12:17 EDTJNJMedivation plummets after Cowen highlights slowing Xtandi trends
Subscribe for More Information
11:23 EDTJNJMedivir says Janssen's Alios BIopharma starts Phase I AL-704 trial
Subscribe for More Information
10:36 EDTINTCLockheed Martin launches healthcare technology alliance
Lockheed Martin (LMT) announced the formation of a new healthcare technology alliance, combining the expertise of health IT providers, medical technology companies, and academic institutions to advance public health. The Lockheed Martin Healthcare Technology Alliance's founding members include: Cisco (CSCO), Cloudera, Illumina (ILMN), Intel (INTC) and Montgomery College. The members of the Lockheed Martin Healthcare Technology Alliance will collaborate on technology solutions that help improve care in rapidly evolving and growing areas of health technology such as those that: secure patient medical information; leverage advances in genomic research; and apply big data solutions to improve public health.
06:29 EDTINTCIntel defines 6 desktop market segments for CPU platforms, DigiTimes reports
Subscribe for More Information
July 28, 2015
16:53 EDTINTCOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
16:00 EDTINTCOptions Update; July 28, 2015
Subscribe for More Information
14:57 EDTINTCAnalyst skeptical after 'amateurish' Micron, Intel memory presentation
Subscribe for More Information
13:57 EDTINTCMicron, Intel memory launch more diversion than revolution, says Summit Research
After Micron (MU) and Intel (INTC) introduced 3D XPoint memory technology, Summit Research analyst Srini Sundararajan said that at first glance the new product seems like an additive memory that will co-exist with DRAM and NAND. Sundararajan added that nothing about the "amateurish" presentation gives him confidence that Micron and Intel can catch Samsung (SSNLF) in terms of DRAM or 3D NAND.
12:43 EDTINTCIntel, Micron downplay concerns of 3D XPoint 'cannibalizing' NAND products
Subscribe for More Information
12:31 EDTINTCIntel, Micron expect 3D XPoint cost to be 'somewhere between' NAND, DRAM
Subscribe for More Information
12:08 EDTINTCIntel, Micron introduce 3D XPoint memory technology
Intel (INTC) and Micron Technology (MU) unveiled 3D XPoint technology, a non-volatile memory that the companies say has the potential to "revolutionize any device, application or service that benefits from fast access to large sets of data." Now in production, 3D XPoint technology brings non-volatile memory speeds up to 1,000 times faster than NAND, according to Intel and Micron. 3D XPoint technology will sample later this year with select customers, and Intel and Micron are developing individual products based on the technology, the companies said.
12:02 EDTINTCMicron, Intel to discuss technology similar to HP memristor, Hesseldahl says
Arik Hesseldahl of Re/code said on Twitter: "Intel and Micron are going to disclose technology similar to HP's memristor technology. It will be called: 3D XPoint" Reference Link
08:38 EDTINTCIntel and Micron to hold a joint press and analyst webcast
Micron and Intel Share Updates on Latest Storage and Memory Technologies in a webcast being held on July 28 at 12 pm. Reference Link
07:59 EDTINTCKLA-Tencor downgraded to Sell from Neutral at Citi
Subscribe for More Information
07:20 EDTVRTXBrookings Institute to hold a public meeting
Subscribe for More Information
07:05 EDTJNJMacroGenics reports MGD011 advances into clinical development
Subscribe for More Information
July 27, 2015
16:00 EDTINTCOptions Update; July 27, 2015
Subscribe for More Information
10:47 EDTINTCQualcomm rises in down market after Morgan Stanley upgrade
Subscribe for More Information
10:40 EDTJNJLeerink major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
10:35 EDTINTCIntel, Micron gain after announcing joint press event
Subscribe for More Information
09:36 EDTINTCActive equity options trading on open
Active equity options trading on open: AAPL NFLX INTC MU VZ BIDU AMBA
06:36 EDTINTCIntel to adopt Skylake CPUs in NUC and Computer Stick, DigiTimes reports
Subscribe for More Information
July 24, 2015
06:13 EDTINTCAnalysts say Intel best suitor for Qualcomm's chip unit, Reuters says
Subscribe for More Information
July 23, 2015
18:21 EDTBSXOn The Fly: Top stock stories for Thursday
Stocks began the session mixed on the heels of weak earnings reports from both Caterpillar (CAT) and 3M (MMM). The Nasdaq managed to spend most of the day in positive territory but joined the other averages in negative territory by mid-afternoon. Selling picked up momentum towards late afternoon, and by day’s end each of the averages were lower by more than 0.4%, with the Dow losing nearly 0.7%. ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 255,000 in the week ended July 18, below the 278,000 first-time claims that were expected. The Leading Economic Indicators advanced 0.6% in June, exceeding expectations for a 0.3% increase. In Asia, the Shanghai Composite index advanced for a sixth straight session, adding another 2.4%. In Europe, the Greek Parliament voted to accept creditor terms for a new bailout, though a decision on when to reopen Greek financial markets was deferred to next week. COMPANY NEWS: Shares of General Motors (GM) finished the session up 3.96% to $31.50 after reporting earnings per share above analyst expectations. Other notable names rising following earnings reports include SanDisk (SNDK), Under Armour (UA), Southwest (LUV)... Caterpillar, meanwhile, dropped $2.86, or 3.59%, to $76.90 after cutting its yearly guidance during this morning's earnings report, with the company noting a "relatively stagnant" global economy. Also lower following earnings were Comcast (CMCSA, CMCSK), Bristol-Myers Squibb (BMY), Dunkin Brands (DNKN), and Boston Scientific (BSX). MAJOR MOVERS: Among the notable gainers was Cigna (CI), which rose $3.29, or 2.18%, to $154.36 after the Wall Street Journal reported last night that Anthem (ANTM) is nearing a deal to acquire the company for roughly $187, representing a total transaction value of over $48B. Adding to that report, CNBC's David Faber said on Thursday morning that Anthem will announce an agreement Friday to purchase Cigna for $188 per share, at a 45% equity, 55% cash split. Also higher were shares of numerous IT security companies, with FireEye (FEYE) advancing 4.53% and Palo Alto Networks (PANW) adding 2.33% after earnings reports from security firms Fortinet (FTNT) and F5 Networks (FFIV) beat on both top and bottom lines. Fortinet and F5, meanwhile, finished Thursday's session up 10.71% and 7.75% to $46.83 and $127.68, respectively. Among the noteworthy losers following earnings was McDonald's (MCD), which edged down 0.52% to $97.10 after noting that Q2 global comparable sales fell 0.7% for the quarter, including a 2% decline in U.S. same-store sales. Also lower was Hertz (HTZ), which declined 8.53% to $16.45 following a downgrade to Underweight at Morgan Stanley, with the research firm citing increased competition from Uber and similar mobility services. INDEXES: The Dow fell 119.12, or 0.67%, to 17,731.92, the Nasdaq lost 25.36, or 0.49%, to 5,146.41, and the S&P 500 declined 12.00, or 0.57%, to 2,102.15.
17:51 EDTJNJJanssen submits sNDA to update label for Olysio
Subscribe for More Information
15:27 EDTBSXBoston Scientific weakness a buying opportunity, says BofA/Merrill
Subscribe for More Information
12:04 EDTINTCRackspace, Intel announce OpenStack collaboration
Subscribe for More Information
07:56 EDTBSXBoston Scientific reports Q2 Cardiovascular sales $743M
Subscribe for More Information
07:06 EDTBSXBoston Scientific backs FY15 adjusted EPS 88c-92c, consensus 90c
Subscribe for More Information
07:05 EDTBSXBoston Scientific sees Q3 adjusted EPS 21c-23c, consensus 23c
Subscribe for More Information
07:04 EDTBSXBoston Scientific reports Q2 adjusted EPS 22c, consensus 21c
Subscribe for More Information
06:22 EDTINTCIntel to release notebook Skylake processor in October, DigiTimes reports
Intel is expected to release its upcoming notebook Skylake processor in October, reports DigiTimes. The company is planning to launch a total of 18 notebook Skylake processors in Q4 as it looks to help boost notebook demand. The company is adjusting their schedules for Skylake products to minimize the impact of inventory issues. Reference Link
July 22, 2015
15:26 EDTBSXNotable companies reporting before tomorrow's open
Subscribe for More Information
14:51 EDTINTCEarnings Watch: Qualcomm reports after speculations of potential breakup
Qualcomm (QCOM) is expected to report third quarter earnings after the close on July 22, with a conference call scheduled for 4:45 pm ET. Qualcomm is a maker of semiconductors and telecommunications equipment. EXPECTATIONS: Analysts are looking for earnings per share of 95c on revenue of $5.85B. EPS consensus ranges 90c-$1.05 on a revenue range of $5.59B-$6.08B, according to First Call. LAST QUARTER: On April 22, Qualcomm reported Q2 EPS of $1.40 against expectations for $1.33, and revenue of $6.89B versus estimates of $6.83B. The company also cut its FY15 EPS guidance to $4.60-$5.00 from $4.85-$5.05 and lowered projected revenue to $25B-$27B from $26.3B-$28B, saying it expects pressure in its semiconductor business due to customer shifts in the premium segment and a decline in Qualcomm's share at an unnamed large customer. NEWS: On May 8, Reuters reported that EU antitrust regulators asked Qualcomm's competitors how the company's licensing and business practices affect them, and on July 16, the European Commission confirmed two formal antitrust investigations of the company. On May 25, Qualcomm and Daimler (DDAIF) announced a strategic collaboration to develop connected car technology. Coming on the heels of Avago's (AVGO) May 28 agreement to acquire Broadcom (BRCM), Bloomberg quoted a source later that day as saying Qualcomm, Intel (INTC), Altera (ALTR), Analog Devices (ADI), Maxim Integrated (MXIM), Texas Instruments (TXN), and Microchip Technology (MCHP) are all considering their own M&A opportunities. Note that on June 1, Intel announced an agreement to acquire Altera. On June 23, Semiconductor Manufacturing International (SMI), Qualcomm, Huawei, and Imec announced the formation of a joint venture to focus on a type of 14 nanometer technology. More recently, the Wall Street Journal reported on July 20 that Qualcomm is "expected" to begin a comprehensive strategic review which may include the possibility of a breakup following pressure from "activist" shareholder Jana Partners, according to sources, adding that the move could be announced concurrent with Wednesday's earnings release. STREET RESEARCH: Following last quarter's earnings report, Exane BNP Paribas downgraded Qualcomm to Neutral from Outperform, while both Canaccord and Brean Capital lowered price targets for the stock after "disappointing" guidance. Meanwhile, Citi said it expects the company's chip business to recover in 2016 despite this "very bad year." On May 28, CLSA said it sees continued pressure on Qualcomm chipsets, potentially spurring the company to consider making an acquisition, and on June 2, Craig-Hallum noted that Skyworks (SWKS) would be a great fit for Qualcomm. On June 24, Summit Research called Applied Micro Circuits (AMCC) an "affordable" target for Qualcomm, with AMD (AMD) and Cavium (CAVM) also looking like potential takeover candidates. On June 29, Drexel Hamilton downgraded Qualcomm to Sell from Hold, citing expected price cuts. Lastly, following media reports on July 20 that Qualcomm could be weighing a breakup, Bernstein said that such a "dis-synergistic" split would likely destroy value rather than create it. PRICE ACTION: Shares of Qualcomm are down more than 1% to $64.37 in afternoon trading ahead of Wednesday's earnings report.
10:15 EDTJNJ, MDTThoratec downgraded to Market Perform from Outperform at Northland
Subscribe for More Information
06:15 EDTINTCGoogle's updated Glass to be foldable, more weather-resistant, 9to5Google says
Subscribe for More Information
July 21, 2015
07:22 EDTBSXBoston Scientific should be bought on pullbacks, says RBC Capital
RBC Capital expects Boston Scientific to report slightly higher than expected Q2 EPS and in-line revenue. The firm expects the company's results to be boosted by strength in ICDs and OUS DES stents. RBC is confident that the company's EPS can grow by low teen percentage levels over the long-term and recommends buying the shares on pullbacks.
July 20, 2015
09:34 EDTINTCActive equity options trading on open
Subscribe for More Information
09:08 EDTBSXBoston Scientific begins study of resorbable drug-eluting scaffold system
Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study, or FAST, is a prospective, single arm study designed to assess the safety and performance of this next generation scaffold for the treatment of atherosclerotic coronary lesions.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use